AR126482A1 - ANTIVIRAL AGENTS DERIVED FROM SPIROPYRROLIDINE - Google Patents
ANTIVIRAL AGENTS DERIVED FROM SPIROPYRROLIDINEInfo
- Publication number
- AR126482A1 AR126482A1 ARP220101882A ARP220101882A AR126482A1 AR 126482 A1 AR126482 A1 AR 126482A1 AR P220101882 A ARP220101882 A AR P220101882A AR P220101882 A ARP220101882 A AR P220101882A AR 126482 A1 AR126482 A1 AR 126482A1
- Authority
- AR
- Argentina
- Prior art keywords
- formula
- pharmaceutically acceptable
- spiropyrrolidine
- antiviral agents
- subject
- Prior art date
Links
- 239000003443 antiviral agent Substances 0.000 title 1
- 150000001875 compounds Chemical class 0.000 abstract 3
- 150000003839 salts Chemical class 0.000 abstract 3
- 241000711573 Coronaviridae Species 0.000 abstract 1
- 208000001528 Coronaviridae Infections Diseases 0.000 abstract 1
- 125000001072 heteroaryl group Chemical group 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 230000010076 replication Effects 0.000 abstract 1
- 125000003107 substituted aryl group Chemical group 0.000 abstract 1
Abstract
La presente invención revela compuestos de fórmula (1), en donde B es un arilo opcionalmente sustituido o un heteroarilo opcionalmente sustituido, y sales de uso farmacéutico aceptable de los mismos, que inhibe la actividad de replicación del coronavirus. La invención además se relaciona a composiciones farmacéuticas que comprenden un compuesto de fórmula (1) o una sal de uso farmacéutico aceptable del mismo y métodos para tratar o prevenir una infección por coronavirus en un sujeto que lo necesite que comprende administrar al sujeto una cantidad terapéuticamente efectiva de un compuesto de fórmula (1) o una sal de uso farmacéutico aceptable del mismo.The present invention discloses compounds of formula (1), wherein B is an optionally substituted aryl or an optionally substituted heteroaryl, and pharmaceutically acceptable salts thereof, which inhibit the replication activity of the coronavirus. The invention further relates to pharmaceutical compositions comprising a compound of formula (1) or a pharmaceutically acceptable salt thereof and methods of treating or preventing a coronavirus infection in a subject in need thereof comprising administering to the subject a therapeutically administered amount effective of a compound of formula (1) or a pharmaceutically acceptable salt thereof.
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063324367P | 2020-03-28 | 2020-03-28 | |
| US202017479248A | 2020-09-20 | 2020-09-20 | |
| US202162227206P | 2021-07-20 | 2021-07-20 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR126482A1 true AR126482A1 (en) | 2023-10-11 |
Family
ID=88679340
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP220101882A AR126482A1 (en) | 2020-03-28 | 2022-07-19 | ANTIVIRAL AGENTS DERIVED FROM SPIROPYRROLIDINE |
Country Status (1)
| Country | Link |
|---|---|
| AR (1) | AR126482A1 (en) |
-
2022
- 2022-07-19 AR ARP220101882A patent/AR126482A1/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CL2023000167A1 (en) | Functionalized peptides as antiviral agents | |
| UY39529A (en) | NEW ANTIVIRAL AGENTS DERIVED FROM SPIROPYRROLIDINE | |
| MX2021013679A (en) | Nitrile-containing antiviral compounds. | |
| BR112022025037A2 (en) | ANTIVIRAL COMPOUNDS TO TREAT CORONAVIRUS, PICORNAVIRUS AND NOROVIRUS INFECTIONS | |
| CO2023002852A2 (en) | Functionalized peptides as antiviral agents | |
| EA200702445A1 (en) | THIAZOLE COMPOUNDS AND METHODS OF THEIR APPLICATION | |
| UY39032A (en) | HETEROCYCLIC COMPOUNDS AS ANTIVIRAL AGENTS | |
| RU2013121788A (en) | HIV REPLICATION INHIBITORS | |
| DOP2023000060A (en) | LINE-1 INHIBITORS TO TREAT DISEASES BACKGROUND OF THE INVENTION | |
| UY38614A (en) | BENZODIAZEPINE DERIVATIVES AS RSV INHIBITORS | |
| CO4130200A1 (en) | HELPFUL HIV PROTEASE INHIBITORS IN AIDS TREATMENT | |
| BR112022018173A2 (en) | COMPOUND OF FORMULA (I) OR A PHARMACEUTICALLY ACCEPTABLE SALT THEREOF, PHARMACEUTICAL COMPOSITION, COMPOUND FOR THE USE AND USE OF A COMPOUND OF FORMULA (I) OR A PHARMACEUTICALLY ACCEPTABLE SALT THEREOF | |
| AR127247A1 (en) | CYCLOPENTYLPYRAZOLE CDK2 INHIBITORS | |
| AR126482A1 (en) | ANTIVIRAL AGENTS DERIVED FROM SPIROPYRROLIDINE | |
| CL2023000418A1 (en) | Heteroaryl-substituted spiropiperidinyl derivatives and pharmaceutical uses thereof | |
| AR126501A1 (en) | NEW ANTIVIRAL AGENTS DERIVED FROM SPIROPYRROLIDINE | |
| CL2023000270A1 (en) | Compound for the treatment of Alzheimer's disease | |
| PE20231945A1 (en) | REGIMES FOR THE TREATMENT OF HAIR LOSS DISORDERS WITH DEUTERATED JAK INHIBITORS | |
| AR122280A1 (en) | ANTIVIRAL HETEROCYCLIC COMPOUNDS | |
| MX9203068A (en) | ORALALLY ACTIVE ACTIVIRAL COMPOUNDS. | |
| AR118379A1 (en) | BENZODIAZEPINE DERIVATIVES AS RSV INHIBITORS | |
| UY39642A (en) | ANTIVIRAL HETEROCYCLIC COMPOUNDS | |
| CL2022001935A1 (en) | Antiviral compounds containing nitrile | |
| AR126835A1 (en) | DEUTERATED ANALOGS AND DERIVATIVES OF 4-BROMO-2,5-DIMETHOXYPHENETHYLAMINE AND USES OF THESE | |
| AR126702A1 (en) | PHOSPHOLIPID COMPOUNDS AND METHODS OF PREPARATION AND USE THEREOF |